Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Autochthonous cases of Zika virus in metropolitan France: a new paradigm for this arbovirus ?

Salinas S, Simonin Y, L'Ambert G, Nisole S.

Virologie (Montrouge). 2019 Dec 1;23(6):329-332. doi: 10.1684/vir.2019.0804. No abstract available.

PMID:
31859256
2.

TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells.

Maarifi G, Smith N, Maillet S, Moncorgé O, Chamontin C, Edouard J, Sohm F, Blanchet FP, Herbeuval JP, Lutfalla G, Levraud JP, Arhel NJ, Nisole S.

Sci Adv. 2019 Nov 20;5(11):eaax3511. doi: 10.1126/sciadv.aax3511. eCollection 2019 Nov.

3.

Cerpegin-derived furo[3,4-c]pyridine-3,4(1H,5H)-diones enhance cellular response to interferons by de novo pyrimidine biosynthesis inhibition.

Hayek S, Pietrancosta N, Hovhannisyan AA, Alves de Sousa R, Bekaddour N, Ermellino L, Tramontano E, Arnould S, Sardet C, Dairou J, Diaz O, Lotteau V, Nisole S, Melikyan G, Herbeuval JP, Vidalain PO.

Eur J Med Chem. 2020 Jan 15;186:111855. doi: 10.1016/j.ejmech.2019.111855. Epub 2019 Nov 6.

PMID:
31740051
4.

Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating.

Fernandez J, Machado AK, Lyonnais S, Chamontin C, Gärtner K, Léger T, Henriquet C, Garcia C, Portilho DM, Pugnière M, Chaloin L, Muriaux D, Yamauchi Y, Blaise M, Nisole S, Arhel NJ.

Nat Microbiol. 2019 Nov;4(11):1840-1850. doi: 10.1038/s41564-019-0575-6. Epub 2019 Oct 14.

PMID:
31611641
5.

Langerin (CD207) represents a novel interferon-stimulated gene in Langerhans cells.

Maarifi G, Czubala MA, Lagisquet J, Ivory MO, Fuchs K, Papin L, Birchall JC, Nisole S, Piguet V, Blanchet FP.

Cell Mol Immunol. 2019 Oct 13. doi: 10.1038/s41423-019-0302-5. [Epub ahead of print] No abstract available.

PMID:
31607745
6.

Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment.

Smith N, Rodero MP, Bekaddour N, Bondet V, Ruiz-Blanco YB, Harms M, Mayer B, Bader-Meunier B, Quartier P, Bodemer C, Baudouin V, Dieudonné Y, Kirchhoff F, Sanchez Garcia E, Charbit B, Leboulanger N, Jahrsdörfer B, Richard Y, Korganow AS, Münch J, Nisole S, Duffy D, Herbeuval JP.

Sci Adv. 2019 Jul 10;5(7):eaav9019. doi: 10.1126/sciadv.aav9019. eCollection 2019 Jul.

7.

[SUMO regulates the capacity of TRIM5α to inhibit HIV-1].

Nisole S, Fernandez J, Maarifi G, Arhel NJ.

Med Sci (Paris). 2019 Feb;35(2):106-109. doi: 10.1051/medsci/2019016. Epub 2019 Feb 18. French. No abstract available.

PMID:
30774075
8.

RanBP2 regulates the anti-retroviral activity of TRIM5α by SUMOylation at a predicted phosphorylated SUMOylation motif.

Maarifi G, Fernandez J, Portilho DM, Boulay A, Dutrieux J, Oddos S, Butler-Browne G, Nisole S, Arhel NJ.

Commun Biol. 2018 Nov 15;1:193. doi: 10.1038/s42003-018-0198-0. eCollection 2018.

9.

Identification of Primary Natural Killer Cell Modulators by Chemical Library Screening with a Luciferase-Based Functional Assay.

Hayek S, Bekaddour N, Besson L, Alves de Sousa R, Pietrancosta N, Viel S, Smith N, Jacob Y, Nisole S, Mandal R, Wishart DS, Walzer T, Herbeuval JP, Vidalain PO.

SLAS Discov. 2019 Jan;24(1):25-37. doi: 10.1177/2472555218797078. Epub 2018 Sep 5.

PMID:
30184441
10.

Original Chemical Series of Pyrimidine Biosynthesis Inhibitors That Boost the Antiviral Interferon Response.

Lucas-Hourani M, Dauzonne D, Munier-Lehmann H, Khiar S, Nisole S, Dairou J, Helynck O, Afonso PV, Tangy F, Vidalain PO.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00383-17. doi: 10.1128/AAC.00383-17. Print 2017 Oct.

11.

Identification of a small molecule that primes the type I interferon response to cytosolic DNA.

Khiar S, Lucas-Hourani M, Nisole S, Smith N, Helynck O, Bourgine M, Ruffié C, Herbeuval JP, Munier-Lehmann H, Tangy F, Vidalain PO.

Sci Rep. 2017 May 31;7(1):2561. doi: 10.1038/s41598-017-02776-z.

12.

Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement.

Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, Dy M, Scott-Algara D, Manoury B, Zirafi O, McCort-Tranchepain I, Durroux T, Bachelerie F, Schwartz O, Münch J, Wack A, Nisole S, Herbeuval JP.

Nat Commun. 2017 Feb 9;8:14253. doi: 10.1038/ncomms14253.

13.
14.

MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.

Maarifi G, Hannoun Z, Geoffroy MC, El Asmi F, Zarrouk K, Nisole S, Blondel D, Chelbi-Alix MK.

J Virol. 2016 Jun 24;90(14):6598-6610. doi: 10.1128/JVI.00722-16. Print 2016 Jul 15.

15.

[SUMO paralogs and interferon response].

Maarifi G, Dianoux L, Nisole S, Chelbi-Alix MK.

Med Sci (Paris). 2016 Feb;32(2):141-3. doi: 10.1051/medsci/20163202002. Epub 2016 Mar 2. French. No abstract available.

16.

Endogenous TRIM5α Function Is Regulated by SUMOylation and Nuclear Sequestration for Efficient Innate Sensing in Dendritic Cells.

Portilho DM, Fernandez J, Ringeard M, Machado AK, Boulay A, Mayer M, Müller-Trutwin M, Beignon AS, Kirchhoff F, Nisole S, Arhel NJ.

Cell Rep. 2016 Jan 12;14(2):355-69. doi: 10.1016/j.celrep.2015.12.039. Epub 2015 Dec 31.

17.

PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx.

Dutrieux J, Maarifi G, Portilho DM, Arhel NJ, Chelbi-Alix MK, Nisole S.

PLoS Pathog. 2015 Nov 13;11(11):e1005280. doi: 10.1371/journal.ppat.1005280. eCollection 2015 Nov.

18.

Small Ubiquitin-like Modifier Alters IFN Response.

Maarifi G, Maroui MA, Dutrieux J, Dianoux L, Nisole S, Chelbi-Alix MK.

J Immunol. 2015 Sep 1;195(5):2312-24. doi: 10.4049/jimmunol.1500035. Epub 2015 Jul 29.

19.

Resistance to Rhabdoviridae Infection and Subversion of Antiviral Responses.

Blondel D, Maarifi G, Nisole S, Chelbi-Alix MK.

Viruses. 2015 Jul 7;7(7):3675-702. doi: 10.3390/v7072794. Review.

20.

TRIM5α is a SUMO substrate.

Dutrieux J, Portilho DM, Arhel NJ, Hazan U, Nisole S.

Retrovirology. 2015 Mar 24;12:28. doi: 10.1186/s12977-015-0155-7.

21.

MxA interacts with and is modified by the SUMOylation machinery.

Brantis-de-Carvalho CE, Maarifi G, Gonçalves Boldrin PE, Zanelli CF, Nisole S, Chelbi-Alix MK, Valentini SR.

Exp Cell Res. 2015 Jan 1;330(1):151-63. doi: 10.1016/j.yexcr.2014.10.020. Epub 2014 Oct 31.

PMID:
25447205
22.

Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.

Zebboudj A, Maroui MA, Dutrieux J, Touil-Boukoffa C, Bourouba M, Chelbi-Alix MK, Nisole S.

Biochimie. 2014 Dec;107 Pt B:247-56. doi: 10.1016/j.biochi.2014.09.002. Epub 2014 Sep 21.

PMID:
25241256
23.

[Implication of PML nuclear bodies in intrinsic and innate immunity].

Maroui MA, El Asmi F, Dutrieux J, Chelbi-Alix MK, Nisole S.

Med Sci (Paris). 2014 Aug-Sep;30(8-9):765-71. doi: 10.1051/medsci/20143008014. Epub 2014 Sep 1. Review. French.

24.

PML control of cytokine signaling.

Maarifi G, Chelbi-Alix MK, Nisole S.

Cytokine Growth Factor Rev. 2014 Oct;25(5):551-61. doi: 10.1016/j.cytogfr.2014.04.008. Epub 2014 May 9. Review.

PMID:
24861946
25.

Implication of PMLIV in both intrinsic and innate immunity.

El Asmi F, Maroui MA, Dutrieux J, Blondel D, Nisole S, Chelbi-Alix MK.

PLoS Pathog. 2014 Feb 27;10(2):e1003975. doi: 10.1371/journal.ppat.1003975. eCollection 2014 Feb.

26.

Differential Roles of PML Isoforms.

Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK.

Front Oncol. 2013 May 22;3:125. doi: 10.3389/fonc.2013.00125. eCollection 2013.

27.

Hyperthermia stimulates HIV-1 replication.

Roesch F, Meziane O, Kula A, Nisole S, Porrot F, Anderson I, Mammano F, Fassati A, Marcello A, Benkirane M, Schwartz O.

PLoS Pathog. 2012;8(7):e1002792. doi: 10.1371/journal.ppat.1002792. Epub 2012 Jul 12.

28.

HIV-derived vectors for therapy and vaccination against HIV.

Di Nunzio F, Félix T, Arhel NJ, Nisole S, Charneau P, Beignon AS.

Vaccine. 2012 Mar 28;30(15):2499-509. doi: 10.1016/j.vaccine.2012.01.089. Epub 2012 Feb 13. Review.

PMID:
22342915
29.

Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.

Maudet C, Bertrand M, Le Rouzic E, Lahouassa H, Ayinde D, Nisole S, Goujon C, Cimarelli A, Margottin-Goguet F, Transy C.

J Biol Chem. 2011 Jul 8;286(27):23742-52. doi: 10.1074/jbc.M111.220780. Epub 2011 May 12.

30.

The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages.

Bergamaschi A, David A, Le Rouzic E, Nisole S, Barré-Sinoussi F, Pancino G.

J Virol. 2009 Dec;83(23):12253-65. doi: 10.1128/JVI.01395-09. Epub 2009 Sep 16.

31.

Human TRIM gene expression in response to interferons.

Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, Margottin-Goguet F, Mothes W, Hazan U, Transy C, Pancino G, Nisole S.

PLoS One. 2009;4(3):e4894. doi: 10.1371/journal.pone.0004894. Epub 2009 Mar 17.

32.

The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection.

Bergamaschi A, Ayinde D, David A, Le Rouzic E, Morel M, Collin G, Descamps D, Damond F, Brun-Vezinet F, Nisole S, Margottin-Goguet F, Pancino G, Transy C.

J Virol. 2009 May;83(10):4854-60. doi: 10.1128/JVI.00187-09. Epub 2009 Mar 4.

33.

Lack of endogenous TRIM5alpha-mediated restriction in rhesus macaque dendritic cells.

Arhel NJ, Nisole S, Carthagena L, Coutant F, Souque P, Brussel A, Estaquier J, Charneau P.

Blood. 2008 Nov 1;112(9):3772-6. doi: 10.1182/blood-2008-04-151761. Epub 2008 Aug 14.

PMID:
18703703
34.

Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities.

Carthagena L, Parise MC, Ringeard M, Chelbi-Alix MK, Hazan U, Nisole S.

Retrovirology. 2008 Jul 9;5:59. doi: 10.1186/1742-4690-5-59.

35.

Antiviral properties of two trimeric recombinant gp41 proteins.

Delcroix-Genête D, Quan PL, Roger MG, Hazan U, Nisole S, Rousseau C.

Retrovirology. 2006 Mar 3;3:16.

36.

TRIM family proteins: retroviral restriction and antiviral defence.

Nisole S, Stoye JP, Saïb A.

Nat Rev Microbiol. 2005 Oct;3(10):799-808. Review.

PMID:
16175175
37.
38.

A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

Nisole S, Lynch C, Stoye JP, Yap MW.

Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13324-8. Epub 2004 Aug 23.

39.

Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

Yap MW, Nisole S, Lynch C, Stoye JP.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10786-91. Epub 2004 Jul 12.

40.

Early steps of retrovirus replicative cycle.

Nisole S, Saïb A.

Retrovirology. 2004 May 14;1:9. Review.

41.

The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor.

Said EA, Krust B, Nisole S, Svab J, Briand JP, Hovanessian AG.

J Biol Chem. 2002 Oct 4;277(40):37492-502. Epub 2002 Jul 29.

42.
43.

The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells.

Nisole S, Said EA, Mische C, Prevost MC, Krust B, Bouvet P, Bianco A, Briand JP, Hovanessian AG.

J Biol Chem. 2002 Jun 7;277(23):20877-86. Epub 2002 Mar 27.

44.

Inhibition of HIV infection by the cytokine midkine.

Callebaut C, Nisole S, Briand JP, Krust B, Hovanessian AG.

Virology. 2001 Mar 15;281(2):248-64.

45.

The cell-surface-expressed nucleolin is associated with the actin cytoskeleton.

Hovanessian AG, Puvion-Dutilleul F, Nisole S, Svab J, Perret E, Deng JS, Krust B.

Exp Cell Res. 2000 Dec 15;261(2):312-28.

PMID:
11112338
46.

The HB-19 pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits attachment of T lymophocyte- and macrophage-tropic HIV to permissive cells.

Nisole S, Krust B, Dam E, Bianco A, Seddiki N, Loaec S, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG.

AIDS Res Hum Retroviruses. 2000 Feb 10;16(3):237-49.

PMID:
10710212
47.

The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans.

Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG.

J Biol Chem. 1999 Sep 24;274(39):27875-84.

48.

The V3 loop-mimicking pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits HIV infection in primary macrophage cultures.

Seddiki N, Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG.

AIDS Res Hum Retroviruses. 1999 Mar 1;15(4):381-90.

PMID:
10082122
49.

Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype.

Dumonceaux J, Nisole S, Chanel C, Quivet L, Amara A, Baleux F, Briand P, Hazan U.

J Virol. 1998 Jan;72(1):512-9.

Supplemental Content

Loading ...
Support Center